Organisations can apply for a share of £2 million, inclusive of VAT, to develop and commercialise non‑animal methods for assessing the pre‑clinical pharmacokinetics and cardiovascular safety of new medicines.
Eligibility summary
To lead a project, you can:
- be an organisation of any size, including those based in the EU, EEA or internationally
- work alone or with other organisations as subcontractors
Contracts will be awarded to a single legal entity only.